Anjali Singh &Amp;Amp; Subrata Panda

Stories by Anjali Singh &Amp;Amp; Subrata Panda

RBI Keeps Tata Sons Waiting

RBI Keeps Tata Sons Waiting

Rediff.com   1 days ago

The RBI once again said the Tata group holding company's application for deregistration as an NBFC remains under examination.

Tata Sons continues as 'upper-layer NBFC'; listing application pending

Tata Sons continues as 'upper-layer NBFC'; listing application pending

Rediff.com   1 days ago

Tata Sons, the holding company of the Tata group, continues to be classified as an 'upper-layer non-banking financial company' (NBFC) by the Reserve Bank of India (RBI), despite its application to deregister as an NBFC-Core Investment Company (CIC) remaining under consideration. This classification subjects it to enhanced regulation and a mandatory listing requirement, which remains uncertain.

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Rediff.com   6 days ago

Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit to 2,894.7 crore for Q1FY27, with revenue growing 10 per cent to 15,299.8 crore, driven by strong performance in India and innovative medicines.

Bajaj Finance sees 29% profit surge in Q1, driven by robust NII and AUM growth

Bajaj Finance sees 29% profit surge in Q1, driven by robust NII and AUM growth

Rediff.com   31 Jul 2026

Bajaj Finance, India's largest private-sector NBFC, reported a 29 per cent year-on-year increase in standalone net profit to 5,346 crore for Q1FY27, propelled by robust growth in net interest income and assets under management, which surpassed 4 trillion.

Anand Mahindra: M&M must enter attack mode

Anand Mahindra: M&M must enter attack mode

Rediff.com   31 Jul 2026

Mahindra Group Chairman Anand Mahindra announced the company would adopt an 'attack mode' strategy, accelerating investment, innovation, and execution to capitalise on opportunities arising from prolonged geopolitical and economic uncertainty.

RBI allows banks to link bulk deposit rates to liquidity profile

RBI allows banks to link bulk deposit rates to liquidity profile

Rediff.com   31 Jul 2026

The Reserve Bank of India (RBI) has introduced a new framework allowing banks to offer differential interest rates on bulk deposits based on their liquidity characteristics under the Liquidity Coverage Ratio (LCR) framework, while maintaining the principle of uniform pricing across similar deposits.

L&T to invest Rs 5,000 crore in EV components, targeting Tier-I supplier status

L&T to invest Rs 5,000 crore in EV components, targeting Tier-I supplier status

Rediff.com   30 Jul 2026

Larsen & Toubro (L&T) is investing Rs 5,000 crore over five years to enter the automotive components sector, focusing on electric vehicle (EV) motors, safety systems, and connected-vehicle technologies, aiming to become a Tier-I auto supplier.

JLR India gets FTA boost, Q1 sales soar 11 percent

JLR India gets FTA boost, Q1 sales soar 11 percent

Rediff.com   29 Jul 2026

Jaguar Land Rover (JLR) India reported its highest-ever first-quarter retail sales for FY27, with 1,665 vehicles retailed, an 11 per cent year-on-year increase, largely due to sustained demand for premium SUVs and the benefits of the India-UK Free Trade Agreement.

FCNR (B) Inflows May Surpass 2013 Levels in 45 Days, SBI Research Raises Estimates

FCNR (B) Inflows May Surpass 2013 Levels in 45 Days, SBI Research Raises Estimates

Rediff.com   28 Jul 2026

Foreign Currency Non-Resident (Bank), or FCNR (B), deposits mobilised under the Reserve Bank of India's (RBI's) concessional swap facility may have already surpassed the amount raised during the 2013 scheme in just about 45 days, prompting SBI Research to sharply raise its estimate for inflows under the facility to $65-70 billion.

Bank of Baroda Hit by Cyberattack

Bank of Baroda Hit by Cyberattack

Rediff.com   28 Jul 2026

The incident involved compromise of an employee's email account, resulting in unauthorised access to certain data.

Strong H1 Numbers May Propel Passenger Vehicles to Record 2026 Sales

Strong H1 Numbers May Propel Passenger Vehicles to Record 2026 Sales

Rediff.com   27 Jul 2026

India's passenger vehicle industry is poised for a record-breaking year in 2026, propelled by robust dispatches in the first half of the calendar year and strong demand for utility vehicles, despite facing several economic challenges.

PSU Banks Q1FY27: BoB's Profit Dips on Settlement, BoI's Rises on Loan Growth

PSU Banks Q1FY27: BoB's Profit Dips on Settlement, BoI's Rises on Loan Growth

Rediff.com   25 Jul 2026

State-owned Bank of Baroda (BoB) reported a 72 per cent year-on-year (Y-o-Y) drop in net profit to 1,278 crore for Q1FY27 due to a $600 million out-of-court settlement related to NMC Health Plc. In contrast, Bank of India (BoI) saw its net profit rise by 36.23 per cent Y-o-Y to 3,068 crore for the same quarter, driven by healthy loan growth and improved asset quality.

ICICI Bank raises $1 bn in largest dollar issue this year, signalling strong investor confidence

ICICI Bank raises $1 bn in largest dollar issue this year, signalling strong investor confidence

Rediff.com   25 Jul 2026

ICICI Bank has successfully raised $1 billion through a five-year senior unsecured US dollar bond, marking its first public dollar bond issuance since 2017 and the largest single-tranche US dollar bond issuance by an Indian issuer so far this year.

Manipal Health to launch India's largest healthcare IPO on July 29, aiming for Rs 9,275 crore

Manipal Health to launch India's largest healthcare IPO on July 29, aiming for Rs 9,275 crore

Rediff.com   25 Jul 2026

Manipal Health Enterprises is set to launch India's largest healthcare initial public offering (IPO) on July 29, aiming to raise Rs 9,275.22 crore to fund expansion and debt reduction, with the issue closing on July 31.

Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues

Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues

Rediff.com   23 Jul 2026

Dr Reddy's Laboratories reported a 68.7 per cent year-on-year decline in consolidated net profit to Rs 443.5 crore in Q1 FY27, primarily due to the end of its lenalidomide sales agreement, a Rs 240-crore provision for semaglutide API inventory quality issues, and elevated freight costs.

TVS Motor's Q1 net profit jumps 57% on record sales, robust demand across segments

TVS Motor's Q1 net profit jumps 57% on record sales, robust demand across segments

Rediff.com   22 Jul 2026

TVS Motor Company reported a significant 56.8 per cent year-on-year increase in net profit to 1,036 crore in Q1FY27, driven by record sales volumes, an improved product mix, and robust demand in both domestic and international markets, with management anticipating continued double-digit industry growth.

Margin Squeeze Hits Private Bank Stocks; HDFC, Axis Lead Decline

Margin Squeeze Hits Private Bank Stocks; HDFC, Axis Lead Decline

Rediff.com   21 Jul 2026

Shares of major private lenders, including HDFC Bank, Axis Bank, and Kotak Mahindra Bank, experienced a sharp selloff after their June-quarter results indicated persistent pressure on net interest margins (NIMs), despite healthy credit growth. This decline overshadowed gains in ICICI Bank and Punjab National Bank (PNB), which reported resilient or stronger-than-expected earnings.

Geopolitical risks, supply shocks could keep credit-deposit gap elevated: SBI

Geopolitical risks, supply shocks could keep credit-deposit gap elevated: SBI

Rediff.com   21 Jul 2026

A recent SBI Economic Research report indicates that the significant gap between credit and deposit growth, currently over 530 basis points, is likely to persist if geopolitical risks and external supply shocks continue. However, an improvement in deposit growth is anticipated with inflows into foreign currency non-resident (bank) deposits.

First Dengue Vaccine Approved for India

First Dengue Vaccine Approved for India

Rediff.com   21 Jul 2026

The vaccine has been cleared for use in individuals aged 4 to 60 years and can be administered irrespective of whether the taker has had dengue before, eliminating the need for pre-vaccination screening.

HDFC Bank board to soon appoint CEO: Deputy MD

HDFC Bank board to soon appoint CEO: Deputy MD

Rediff.com   20 Jul 2026

HDFC Bank's board is actively discussing the appointment of its new managing director and chief executive officer (MD & CEO) as incumbent Sashidhar Jagdishan's three-year term concludes in October, with the Governance, Nomination and Remuneration Committee (GNRC) expected to finalise the process soon.